Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,855.8
-1.7 (-0.06%)

 

  • STI Straits Times Index
    2,855.8
    -1.7 (-0.06%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,607.6
    -4.5 (-0.28%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,894.7
    75.2 (0.28%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,408.3
    38.6 (1.14%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    26,644.7
    107.4 (0.40%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,783.3
    23.4 (0.41%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,405.7M
  • Value: 1,046.1M
  • Rise: 173
  • Fall: 135
  • Unch: 466

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Alset0.083+0.019
Oceanus^0.025-0.002
Jiutian Chemical0.088+0.001
Sembcorp Marine0.168-0.001
Intl Cement0.071+0.002
QT Vascular0.007-
Broadway Ind0.163+0.006
YZJ Shipbldg SGD0.920-0.010
ThaiBev0.750+0.005
Adventus0.027-

World Indices

World Indices
Name Last Change
Nasdaq 12,094.4 +57.6
HSI 26,894.7 +75.2
HSCEI 10,790.3 +88.8
Jakarta 5,783.3 +23.4
Nikkei 225 26,644.7 +107.4
SSE Comp 3,408.3 +38.6
Shanghai A 3,572.4 +40.5
Shanghai B 244.7 -1.3
KOSPI 2,633.4 +7.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SIERRA ONCOLOGY INC SIERRA ONCOLOGY
Updated on 27 Nov 2020 (End of trading day)
Last (USD): 14.195 Change: -0.465 High: 14.650 Remarks: -
Change (%): -3.17 Low: 14.010
Open 14.650 Yesterday's Close 14.66
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 12,243 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -7.99549 Trailing EPS (USD) e -9.99411 NAV (USD) b 9.5430
PE a - Trailing PE f - Price / NAV b 1.4875
Dividend (USD) d - Cash In Hand (USD) g 9.8739 Issued & Paid-up Shares c 11,040,600
Dividend Yield (%) d - Price / Cash In Hand g 1.438 Treasury Shares h -
Market Cap (M) 156.721 Enterprise Value (M) 48.117
Piotroski F Score 2 Exchange Code SRRA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 87.52 Free Float (%) 43.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Jan 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SIERRA ONCOLOGY INC NASDAQ 156.721 - - 1.4875 -
Industry Biotechnology NASDAQ 2,815.140 458.260 - 6.5922 0.612
Local Peer AMGEN INC NASDAQ 130,877.413 16.689 17.802 11.9425 2.621
Local Peer GILEAD SCIENCES INC NASDAQ 75,249.406 13.971 59.345 4.3135 4.240
Local Peer VERTEX PHARMACEUTICAL NASDAQ 58,953.215 50.096 21.910 7.2482 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 54,852.204 25.925 17.380 5.4172 -
Local Peer MODERNA INC NASDAQ 50,267.041 - - 18.2140 -
Local Peer ILLUMINA INC NASDAQ 46,286.380 46.194 72.549 9.8482 -
Local Peer BIOGEN INC NASDAQ 37,513.354 6.371 7.381 3.4869 -
Local Peer SEAGEN INC NASDAQ 30,493.351 - 64.549 13.5044 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,099.576 11.271 28.329 2.4469 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 26,196.648 - - 24.0810 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 25,910.782 - - 6.0433 -
Local Peer 10X GENOMICS INC NASDAQ 23,812.595 - - 28.8612 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), NOVAVAX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), IMMUNOVANT INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), INSMED INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), ALKERMES PLC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENCOR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), VIELA BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), UNIQURE N.V. (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PRECIGEN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), MACROGENICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CYTOKINETICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), PERSONALIS INC (NASDAQ), COMPUGEN (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ALECTOR INC (NASDAQ), NANTKWEST INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ARVINAS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VAXART INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), AKOUOS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), AGENUS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), IMMATICS N V (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), IVERIC BIO INC (NASDAQ), AVROBIO INC (NASDAQ), GERON CORP (NASDAQ), ATRECA INC (NASDAQ), ARDELYX INC (NASDAQ), ONCORUS INC (NASDAQ), XBIOTECH INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HUMANIGEN INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), AFFIMED N V (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CABALETTA BIO INC (NASDAQ), XOMA CORP (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), MEDICINOVA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), IMV INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHIMERIX INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), METACRINE INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), BIOVIE INC (NASDAQ), EQUILLIUM INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), INMUNE BIO INC (NASDAQ), ORGENESIS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), IMMUNOME INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), CURIS INC (NASDAQ), COHBAR INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SAVARA INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SOLIGENIX INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), HISTOGEN INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ)
Global Peer CSL ASX 137,857.122 43.955 43.955 14.5410 0.969
Global Peer WUXI BIO HKEx 310,653.898 - - - -
Global Peer BEIGENE HKEx 187,206.682 - - 5.6340 -
Global Peer SINO BIOPHARM HKEx 143,158.785 46.642 52.054 4.1462 0.701
Global Peer ZAI LAB-SB HKEx 70,040.774 - - 19.4149 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,389.915 80.549 26.350 3.5077 -
Global Peer GENSCRIPT BIO HKEx 21,062.251 - - 2.8807 -
Global Peer 3SBIO HKEx 18,949.820 17.163 12.621 1.6200 -
Global Peer MYOVANT SCIENCES LTD NYSE 2,131.667 - - -10.6702 -
Other Global Peers ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), VIVA BIOTECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), JW THERAP-B (HKEx), JHBP-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), ASCENTAGE-B (HKEx), DPHARMA (Bursa), TELIX PHARMACEUTIC (ASX), OPTHEA LIMITED (ASX), KINTOR PHARMA-B (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), IMUGENE LIMITED (ASX), ESSEX BIO-TECH (HKEx), NANOVIRICIDES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), NEXT SCIENCE LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), IBIO INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), MEMPHASYS LTD (ASX), BIONOMICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), CT ENTERPRISE (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), GENETIC TECHNOLOGIES (ASX), REGENT PACIFIC (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), Suntar Eco-City (SGX), BIOSINO BIO-TEC (HKEx), CONSTELLATION TECHNOLOGIES LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PATRYS LIMITED (ASX), REGENEUS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ADALTA LTD (ASX), ORAGENICS INC (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CRYOSITE (ASX), HAO WEN HLDGS (HKEx), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.575
-3.89 %
10 Days --0.325
-2.24 %
20 Days -+1.435
+11.25 %
Medium Term Return 3 Months -+1.815
+14.66 %
6 Months -+0.505
+3.69 %
1 Year -+0.999
+7.57 %
Long Term Return 2 Years --53.405
-79.00 %
3 Years --98.605
-87.42 %
Annualised Return Annualised --
-49.89 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.545 - 22.000 Change From 1 Year Low +5.650 % Change From 1 Year Low (%) +66.12
Change From 1 Year High -7.805 % Change From 1 Year High (%) -35.48
2 Years Range 8.545 - 80.400 Change From 2 Years Low +5.650 % Change From 2 Years Low (%) +66.12
Change From 2 Years High -66.205 % Change From 2 Years High (%) -82.34
5 Years Range 8.545 - 163.600 Change From 5 Years Low +5.650 % Change From 5 Years Low (%) +66.12
Change From 5 Years High -149.405 % Change From 5 Years High (%) -91.32
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.

Historical Price Data

Date Open High Low Close Volume VWAP
27 Nov 2020 14.650 14.650 14.010 14.195 12,243 -
25 Nov 2020 14.950 15.000 14.500 14.660 16,163 -
24 Nov 2020 15.206 15.384 14.850 14.960 8,879 -
23 Nov 2020 14.850 15.430 14.740 15.140 10,458 -
20 Nov 2020 14.990 16.000 14.845 15.000 26,380 -
19 Nov 2020 14.800 14.950 14.755 14.798 2,044 -
18 Nov 2020 14.505 14.940 14.505 14.770 2,873 -
17 Nov 2020 14.540 15.050 14.352 14.655 70,326 -
16 Nov 2020 14.860 14.914 14.230 14.560 10,472 -
13 Nov 2020 14.290 14.860 14.290 14.860 7,682 -
12 Nov 2020 14.850 14.850 14.260 14.370 7,457 -
11 Nov 2020 14.220 14.932 14.030 14.520 24,580 -
10 Nov 2020 13.850 14.190 13.850 14.070 7,139 -
09 Nov 2020 14.220 14.300 13.545 14.090 11,480 -
06 Nov 2020 14.050 14.100 13.527 14.050 13,498 -
05 Nov 2020 13.420 14.180 13.420 14.170 18,516 -
04 Nov 2020 13.960 14.080 13.190 13.690 17,345 -
03 Nov 2020 13.370 14.540 13.370 13.790 27,686 -
02 Nov 2020 13.750 14.945 13.440 14.580 48,168 -
30 Oct 2020 13.690 14.164 13.400 13.710 13,396 -
29 Oct 2020 12.800 13.880 12.800 13.670 23,700 -
28 Oct 2020 12.774 12.820 12.567 12.760 7,903 -
Summary
Current 2 Weeks
(13 Nov 2020 to 27 Nov 2020)
14.290 16.000 14.010 14.195 167,520 -
Previous 2 Weeks
(30 Oct 2020 to 12 Nov 2020)
13.690 16.000 13.400 14.370 189,265 -
4 Weeks from
(02 Oct 2020 to 29 Oct 2020)
10.650 16.000 10.600 13.670 778,105 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.